new_0222_0440|HOWL|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0440|HOWL|1|Werewolf Therapeutics Inc PS Ratio|Werewolf Therapeutics Inc Price to Book Value|Werewolf Therapeutics Inc PEG Ratio|Werewolf Therapeutics Inc Price (USD)|Werewolf Therapeutics Inc Short Interest|Werewolf Therapeutics Inc Dividend Yield|Werewolf Therapeutics Inc Earnings Yield|Werewolf Therapeutics Inc Market Cap (USD)|Werewolf Therapeutics Inc PE Ratio|Werewolf Therapeutics Inc Consensus Recommendation|Werewolf Therapeutics Inc Price Target Num Estimates|Werewolf Therapeutics Inc Price Target (USD)|Werewolf Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Werewolf Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Werewolf Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Werewolf Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Werewolf Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Werewolf Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Werewolf Therapeutics Inc Revenue (Quarterly) (USD)|Werewolf Therapeutics Inc EBITDA (Quarterly) (USD)|Werewolf Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0440|HOWL|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0440|HOWL|4|quarterly|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0440|HOWL|5||1.43827160494||1.44117647059|15.3333333333|1.44117647059|1.44117647059|1.44117647059||11.2222222222|25.25|25.25|182|182|30.3333333333|24.4285714286|63|63||91.3333333333|91.3333333333||
new_0222_0440|HOWL|6||162||204|18|204|204|204||18|8|8|1|1|6|7|1|1||6|6||
new_0222_0440|HOWL|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0440|HOWL|20200315||||||||||||||||||||-3.871|-3.827||
new_0222_0440|HOWL|20200615||||||||||||||||||||-5.023|2.257||
new_0222_0440|HOWL|20200915||||||||||||||||||||-6.012|-6.068||
new_0222_0440|HOWL|20201215||||||||||||||||||||-7.348|-7.402||
new_0222_0440|HOWL|20210315||||||||||||||||||||-7.413|-7.435||
new_0222_0440|HOWL|20210415||||16.1|||-31.969|443.3843|||||||||||||||
new_0222_0440|HOWL|20210515||||16.26|457833||-31.6544|447.7906||1.25|4|26.5|||-2.0467|-1.4667||||||16.03|
new_0222_0440|HOWL|20210615||2.6481||13.81|831209||-37.2701|380.3191||1.25|4|26.5|||-2.06|-1.23||||-10.894|-10.921|13.64|17.44
new_0222_0440|HOWL|20210715||2.9199||19.23|651722||-47.9207|530.1326||||||||||||||20.31|17.42
new_0222_0440|HOWL|20210815||2.5145||16.56|656414||-55.647|456.5261||1.25|4|26.5|||-2.07|-1.545||||||15.66|17.8
new_0222_0440|HOWL|20210915||2.8212||18.58|676614||-49.5971|512.2079||1.2|5|26.4|||-2.1725|-4.7333|-46.7851|-64.0187||-13.728|-13.758|17.75|17.16
new_0222_0440|HOWL|20211015||2.7733||17.25|680018||-52.4564|469.5278||||||||||||||17.65|15.67
new_0222_0440|HOWL|20211115||2.5739||16.01|658280||-56.5192|435.7762||1.2|5|26.2|||-2.265|-4.7233|-46.7851|-64.0187||||16.2|14.49
new_0222_0440|HOWL|20211215||2.2317||13.7|635261||-66.0491|377.8391||1.2|5|26.2||||||||||14.03|11.91
new_0222_0440|HOWL|20220115||1.9906||12.22|725098||-74.0485|337.0215||||||||||||||12|9.11
new_0222_0440|HOWL|20220215||1.3863||8.51|||-106.3305|234.7015||||||||||||||7.73|6.93